Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The recent SEK 8 trim to the Hansa Biopharma price target, to SEK 69, sits ...
Three months after reporting a win in a phase 3 trial of its kidney transplant drug imlifidase—which is likely to pave the way for a first-time approval in the U.S.—Hansa Biopharma has stumbled in a ...
Gretyl wakes at 6 A.M., as usual, but her stomach feels crampy. These are not what her mother calls the “normal” cramps, which gnash her abdomen for four days each month. These fissures poke her ...
Two of the biggest dark web markets have been taken down by law enforcement agencies across the world, the Department of Justice (DoJ) announced today. They included AlphaBay, the biggest ever dark ...
Hansa, a 6 ½-year-old Asian elephant, the first born in captivity in Washington state, died from a previously undiscovered herpes virus, according to officials at the Woodland Park Zoo in Seattle. The ...
At 12 months, mean eGFR was 51.5 mL/min/1.73m 2 in the imlifidase arm versus 19.3 mL/min/1.73m 2 in the control arm with a statistically significant and clinically meaningful difference of 32.2 mL/min ...
LUND, Sweden & EVRY, France--(BUSINESS WIRE)--Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA) and Genethon, a pioneer and a leader in gene therapy research and development for rare genetic diseases, ...
Hansa's chief executive, Renée Aguiar-Lucander. The FDA has started a review of Hansa Biopharma's imlifidase for patients who need a kidney transplant, but for whom finding a donor is particularly ...
Amidst the challenges that the COVID-19 pandemic has created for many professionals trying to make spaces at home work – often with limited technology and ongoing distractions – the variety of options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results